Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody specifically designed to target eotaxin-1 (CCL11), a key chemokine involved in the recruitment of eosinophils to inflammatory sites. This antibody has significant potential for the study of allergic disorders, offering a precise tool for elucidating the role of eotaxin-1 in the pathogenesis of these conditions. Bertilimumab may facilitate the development of therapeutic strategies aimed at modulating immune responses in allergic diseases.
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody specifically designed to target eotaxin-1 (CCL11), a key chemokine involved in the recruitment of eosinophils to inflammatory sites. This antibody has significant potential for the study of allergic disorders, offering a precise tool for elucidating the role of eotaxin-1 in the pathogenesis of these conditions. Bertilimumab may facilitate the development of therapeutic strategies aimed at modulating immune responses in allergic diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
